These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12671130)

  • 21. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
    Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive bacterial vaccine preventable disease sentinel hospital surveillance network: summary of a strategic review and next steps, 2008–2014.
    Wkly Epidemiol Rec; 2014 Dec; 89(49):545-50. PubMed ID: 25485342
    [No Abstract]   [Full Text] [Related]  

  • 23. Pneumococcal vaccination for adults: History and updates.
    Esden JL
    Nurse Pract; 2022 Nov; 47(11):40-47. PubMed ID: 36287736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development.
    Vyse A; Campling J; Czudek C; Ellsbury G; Slack M
    Vaccine; 2020 Dec; 38(51):8068-8070. PubMed ID: 33190949
    [No Abstract]   [Full Text] [Related]  

  • 25. Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
    Horácio AN; Silva-Costa C; Lopes E; Ramirez M; Melo-Cristino J;
    PLoS One; 2018; 13(11):e0206912. PubMed ID: 30388168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children.
    Pelton SI; Klein JO
    Pediatrics; 2002 Oct; 110(4):805-14. PubMed ID: 12359799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.
    Lucero MG; Dulalia VE; Parreno RN; Lim-Quianzon DM; Nohynek H; Makela H; Williams G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004977. PubMed ID: 15495133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era.
    Olarte L; Barson WJ; Bradley JS; Tan TQ; Lin PL; Romero JR; Givner LB; Hoffman JA; Hultén KG; Mason EO; Kaplan SL
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):249-252. PubMed ID: 28510699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases.
    O'Brien KL; Santosham M
    Am J Epidemiol; 2004 Apr; 159(7):634-44. PubMed ID: 15033641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Invasive pneumococcal disease in Germany in the era of pneumococcal conjugate vaccination].
    Imöhl M; van der Linden M
    Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1346-51. PubMed ID: 24914512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
    Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
    Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.
    Palmu AA; Kilpi TM; Rinta-Kokko H; Nohynek H; Toropainen M; Nuorti JP; Jokinen J
    Pediatrics; 2015 Jul; 136(1):e22-7. PubMed ID: 26077477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential indirect effect of conjugate pneumococcal vaccines.
    O'Brien KL; Dagan R
    Vaccine; 2003 May; 21(17-18):1815-25. PubMed ID: 12706665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.
    Wkly Epidemiol Rec; 2007 Mar; 82(12):93-104. PubMed ID: 17380597
    [No Abstract]   [Full Text] [Related]  

  • 37. The preventable burden of pneumococcal disease in the developing world.
    Scott JA
    Vaccine; 2007 Mar; 25(13):2398-405. PubMed ID: 17028081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of population-based surveillance for invasive pneumococcal disease in Bangalore, India.
    Shah AS; Nisarga R; Ravi Kumar KL; Hubler R; Herrera G; Kilgore PE
    Indian J Med Sci; 2009 Nov; 63(11):498-507. PubMed ID: 20075551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.